David Moadel

David Moadel

InvestorPlace Contributor

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Mobilicom (MOB) Stock Gains 12% on Share Buyback Announcement

By David Moadel, InvestorPlace Contributor

MOB stock is surging only a few days after Warren Buffett defended corporate share repurchases in Berkshire Hathaway's annual letter.

Laying Out the Bull Case for Rivian (RIVN) Stock

By David Moadel, InvestorPlace Contributor

Rivian certainly isn't the biggest automaker, but RIVN stock can still ride higher as the company develops new electric-vehicle technology.

Is Amazon (AMZN) Stock a Buy? Here’s My Call.

By David Moadel, InvestorPlace Contributor

AMZN stock can move higher in 2023 as Amazon expands its presence in the healthcare market and pursues an AI-focused partnership.

Why Is Cardio Diagnostics (CDIO) Stock Up 150% Today?

By David Moadel, InvestorPlace Contributor

Cardio Diagnostics embeds AI into its medical products, and CDIO stock is flying high on the announcement of a high-tech blood test.

Adamis Pharmaceuticals (ADMP) Stock Wavers on Merger News

By David Moadel, InvestorPlace Contributor

ADMP stock traders are still deciding whether they're bullish or bearish on Adamis Pharmaceuticals' upcoming business combination.

3 Reasons Why I Still Wouldn’t Touch ARVL Stock With a 10-Foot Pole

By David Moadel, InvestorPlace Contributor

Arrival might try to spin its mega-scale share sale as a positive event, but ARVL stock could still get delisted this year.

My DIS Stock Price Prediction for 2025

By David Moadel, InvestorPlace Contributor

Even as Charlie Munger takes a cautionary tone about Disney's future, DIS stock should still reward long-term investors.

Is Dell Technologies (DELL) a Buy, Sell, or Hold?

By David Moadel, InvestorPlace Contributor

DELL stock traders should be wary now as Dell's move into cloud computing is a case of "too little, too late."

Who’s Giving Up on Rivian Stock – and Who’s Doubling Down?

By David Moadel, InvestorPlace Contributor

RIVN stock has fans among the billionaire class, though not every wealthy investor is increasing his stake in Rivian now.

Is Lucid (LCID) Stock a Buy? Here’s My Call.

By David Moadel, InvestorPlace Contributor

Lucid's fast cash burn and shrinking revenue indicate that LCID stock could fall much further in the coming months.

Load More